KEI Requests the NIH to Investigate Failure to Disclose Federal Funding in Opdivo and Keytruda Patents

On December 20, 2019, Knowledge Ecology International (KEI) filed a request to the National Institutes of Health (NIH) that it investigate an apparent failure to disclose federal funding in patents associated with cancer immunotherapies Opdivo and Keytruda. A court case… Continue Reading

EB146: WHO proposes changes to the modalities of non-State actors’ engagement in WHO’s governing bodies

Currently, the participation of non-State actors in official relations with the World Health Organization (WHO) is regulated by the WHO’s Framework of Engagement with non-State actors (FENSA) which is “a privilege that the Executive Board may grant to nongovernmental organizations,… Continue Reading

CDIP 24: KEI provides comments on the Report on the International Conference on Intellectual Property (IP) and Development

On 20 May 2019, the World Intellectual Property Organization (WIPO) convened an International Conference on Intellectual Property (IP) and Development. On 19 November 2019, at the 24th session of WIPO’s Committee on Development and Intellectual Property (CDIP), Knowledge Ecology International… Continue Reading

KEI, UACT, Public Citizen, SSW, LWC Health Appeal NIH Grant of Exclusive License on Gene Therapy for Cancer to Intima Biosciences

On October 26, 2019, Knowledge Ecology International (KEI), Union for Affordable Cancer Treatment (UACT), Public Citizen, Social Security Works (SSW), LWC Health, Ruth Lopert, Manon Ress, and Terry Love filed an administrative appeal with the National Institutes of Health (NIH).… Continue Reading

KEI and UACT Comments Regarding NIH Exclusive License on GPC3-Expressing Cancer Treatment

On Tuesday November 12, 2019, KEI and the Union for Affordable Cancer Treatment (UACT) filed comments on the National Institutes of Health’s (NIH) “Prospective Grant of an Exclusive Patent License: The Development of an Anti-GPC3 Radionuclide Immunoconjugate for the Treatment… Continue Reading

Trilateral symposium: WTO Director General Roberto Azevêdo highlights the opportunities and challenges faced in providing access to CAR T

On Thursday, 31 October 2019, the World Trade Organization (WTO) hosted the eighth trilateral symposium jointly convened by the World Health Organization (WHO) and the World Intellectual Property Organization (WIPO). The theme of this year’s symposium was ” “Cutting-Edge Health… Continue Reading

WTO TRIPS Council (October 2019): Statement of South Africa on the Transparency of R&D Costs and Pricing of Medicines and Health Technology

On Friday, 18 October 2019, South Africa delivered the following statement at the WTO TRIPS Council on transparency of R&D Costs and Pricing of Medicines and Health Technology. Intellectual Property and the Public Interest: R&D Costs and Pricing of Medicines… Continue Reading